Vault-13

MAAT PHARMA SACA MATPF

COMM · Common Stock · CUSIP F5888J116

1 institutional holders +0 vs Q1 2025
94,18194.2k shares reported held*
$452.1kreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $346.8k (-72.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.80.

Trends to Q2 2025

Institutional holders

Managers reporting a position, each quarter

001Q3 24: 1Q4 24: 1Q1 25: 1Q2 25: 11Q3 24Q4 24Q1 25Q2 25
Numbers
QuarterHolders
Q3 20241
Q4 20241
Q1 20251
Q2 20251

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q4 24: 1 bought or addedQ4 24: 0 cut or sold outQ4 24Q1 25: 1 bought or addedQ1 25: 0 cut or sold outQ1 25Q2 25: 0 bought or addedQ2 25: 1 cut or sold outQ2 25
Numbers
QuarterBought or addedCut or sold out
Q4 202410
Q1 202510
Q2 202501

Biggest buyers

None

Biggest sellers

Propel Bio Management, LLC Reduced -72,242-72.2k

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Propel Bio Management, LLC 0.55% of their portfolio Los Angeles, CA 94,18194.2k $452.1k $452.1k 0.55% Reduced -72.2k -72,242